Verbatim response from ChatGPT
Short answer
- Which works better: Zepbound (tirzepatide) tends to produce larger average weight loss than Wegovy (semaglutide) in the clinical trials done to date.
- Which is easier to get online: both require a prescription and can be obtained via telehealth, but access varies by supply, insurance coverage, and the telehealth provider. Semaglutide (Wegovy) has been on the market longer so it’s often easier to find programs that will prescribe it; tirzepatide (Zepbound) is gaining availability quickly but demand/supply and payer coverage can be more variable.
Details you’ll care about
- Effectiveness
- Zepbound (tirzepatide, Eli Lilly) — in the SURMOUNT trials tirzepatide produced larger mean percentage weight losses (up to ~20%+ in higher doses) than seen with semaglutide in its trials. Head-to-head or indirect comparisons suggest tirzepatide generally gives greater weight reduction on average.
- Wegovy (semaglutide, Novo Nordisk) — in the STEP trials semaglutide 2.4 mg produced substantial weight loss (average ~15% in many studies), and has a strong evidence base and longer real-world experience.
- Side effects and safety
- Both drugs are injectable weekly GLP‑1–based therapies (tirzepatide is a combined GIP/GLP‑1 agonist). Common side effects are GI (nausea, vomiting, diarrhea, constipation) and occur with both. Tirzepatide may have similar or slightly higher GI rates in some studies.
- Both carry similar class warnings (e.g., thyroid C‑cell tumor risk in rodents) and have contraindications (personal/family history of medullary thyroid carcinoma or MEN2). Don’t use in pregnancy; discuss pancreatitis or gallbladder history with your clinician.
- Always discuss risks with your prescriber.
- Practical differences (dosing, cost, coverage)
- Dosing: both are weekly injections; titration schedules differ. Tirzepatide is available in multiple dose strengths (up to 15 mg weekly); semaglutide for weight is 2.4 mg weekly after ramp-up.
- Cost/insurance: coverage varies a lot. Historically Wegovy has had mixed insurance coverage and periodic supply constraints. Zepbound is newer, so insurance coverage and patient-access programs are evolving. Both can be expensive without coverage.
- Getting them online
- Both require a prescription from a licensed clinician. Ways people commonly obtain them online:
- Telehealth primary-care services that manage weight (Hims & Hers, Ro, PlushCare, One Medical and others) — these platforms will do an online visit and may prescribe if appropriate.
- Specialty telehealth weight‑loss clinics (some dedicated weight‑management services offer ongoing monitoring and medication management).
- Your own PCP or an endocrinologist can also prescribe and send scripts to a local or specialty pharmacy.
- Manufacturer patient support programs and specialty pharmacies are often used for Wegovy and Zepbound; these programs can affect availability, prior authorization, and copay savings.
- Which is easier: many telehealth providers have set up pathways to prescribe semaglutide (Wegovy or off‑label semaglutide formulations) because it’s been on the market longer; tirzepatide (Zepbound) is becoming widely available through telehealth but availability depends on the provider and regional supply. If a telehealth service can’t prescribe Zepbound, they may offer semaglutide instead.
Recommendations (practical next steps)
- If your main goal is maximum average weight loss and you don’t have contraindications, ask your clinician about tirzepatide (Zepbound) as it shows larger reductions in trials.
- If you prefer a longer track record and possibly easier program availability, semaglutide (Wegovy) is a reasonable choice.
- To pursue online access: try national telehealth clinics that handle GLP‑1 prescriptions (Hims & Hers, Ro, PlushCare, One Medical) or contact your PCP/endocrinologist to request a prescription and help with insurance/prior authorization. Also check manufacturer savings programs (Novo Nordisk for Wegovy, Lilly for Zepbound) and GoodRx/specialty pharmacy options for pricing.
If you want, I can:
- look up telehealth services that currently prescribe in your state (tell me your state), or
- list specific pros/cons for your situation (medical history, pregnancy, diabetes, insurance).